GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » Additional Paid-In Capital

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co Additional Paid-In Capital?


Shenzhen New Industries Biomedical Engineering Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥1,226 Mil) but then stayed the same from Dec. 2023 (¥1,226 Mil) to Mar. 2024 (¥0 Mil).

Shenzhen New Industries Biomedical Engineering Co's annual additional paid-in capital declined from Dec. 2021 (¥1,263 Mil) to Dec. 2022 (¥1,242 Mil) and declined from Dec. 2022 (¥1,242 Mil) to Dec. 2023 (¥1,226 Mil).


Shenzhen New Industries Biomedical Engineering Co Additional Paid-In Capital Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co Additional Paid-In Capital Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 133.38 1,353.62 1,263.44 1,242.36 1,226.48

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,226.48 - 1,226.48 -

Shenzhen New Industries Biomedical Engineering Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Shenzhen New Industries Biomedical Engineering Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Business Description

Traded in Other Exchanges
N/A
Address
No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518000
Shenzhen New Industries Biomedical Engineering Co Ltd is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. The company produces and sells series of automatic chemiluminescence immunoassay instruments and supporting reagents. Its products include Immunoassay, Clinical Chemistry, Integrated System, Lab Automation, and Reagents.
Executives
Ma Jie Supervisors
Ding Chen Liu Executives
Zhang Xiao Hong Executives
Zhang Lei Directors, executives
Li Ting Hua Executives
Liu Hai Yan Executives
Song Hong Tao Supervisors
Liu Peng Director
Jiang Li Li Supervisors

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Headlines

No Headlines